Benchmark signs first CleanTreat agreements Aquaculture health, genetics and advanced nutrition company Benchmark Holdings has signed its first customer agreements for the delivery of its CleanTreat water purification system, it announced today.
New lice treatment method close to commercial launch Aquaculture biotechnology company Benchmark is on track to commercially launch its novel lice treatment for salmon in the second quarter of this year, it said in a financial report today.
Benchmark hires manager to lead Norway lice treatment launch Benchmark Animal Health has appointed a senior manager to lead the Norway commercial launch of its sea lice medicine, BMK08, and its associated CleanTreat water purification system later this year.
Entries open for top aquaculture award Entries have opened for one of aquaculture’s most prestigious competitions, the Innovation Award presented at the world’s biggest aquaculture event, Aqua Nor, in Trondheim, Norway.
Higher revenue and lower costs boost Benchmark An 8% year-on-year increase in revenue and a reduction in costs helped salmon industry egg supplier Benchmark Holdings make adjusted EBITDA of £300,000 in the third quarter of its 2020 financial year.
Benchmark launch paves way for CleanTreat in Chile Benchmark, the UK based aquaculture health, genetics and nutrition company, today announced the launch of its new business in Chile.
Farming Today turns spotlight on new sea lice treatment The possible use of a new sea lice treatment in Scotland has been discussed on BBC Radio 4’s Farming Today programme.
Mowi asks to trial new lice drug in Scotland Mowi Scotland has taken a first step towards the use of Benchmark’s lice medicine Ectosan in the country’s salmon farming industry.
Benchmark sea lice treatment identity revealed The sea lice treatment developed by Benchmark is the neonicotinoid insecticide imidacloprid, it has been revealed.
Benchmark makes £2m loss for first quarter Aquaculture health, nutrition and genetics business Benchmark Holdings made a loss of nearly £2 million in the first quarter of its 2020 financial year, which starts in October, but said restructuring and cost savings would help it deliver on its expectations for the year.
Benchmark raises £43m from share sale Aquaculture health, nutrition and genetics business Benchmark Holdings today announced that it conditionally raised £43 million by selling shares through an open offer and a market placing.
Benchmark losses rise to £83m after tough year Aquaculture health, advanced nutrition and genetics business Benchmark Holdings has placed the launch of its new BMK08 lice treatment as a priority in 2020 after a tough year in which losses increased to £83 million from £4.4m in 2018.
Benchmark triumphs in Aqua Nor innovation contest Aquaculture health, breeding and nutrition business Benchmark’s CleanTreat system has today won the prestigious Innovation Award at the world’s biggest aquaculture trade fair, Aqua Nor, in Trondheim.
Benchmark short-listed for Aqua Nor Innovation Award Benchmark has been named as one of three finalists for the prestigious Innovation Award to be presented at the world’s biggest aquaculture trade show, Aqua Nor, in Trondheim in August.
